Economic case for universal hepatitis B birth dose vaccination in South Africa.

Benade M, Portnoy A

DOI: 10.1016/j.langlo.2026.104018
Published: 2027 Jun 1
Container: The Lancet. Global health
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.langlo.2026.104018,
  title = {Economic case for universal hepatitis B birth dose vaccination in South Africa.},
  author = {Benade M and Portnoy A},
  year = {2027},
  journal = {The Lancet. Global health},
  doi = {10.1016/j.langlo.2026.104018},
  url = {https://doi.org/10.1016/j.langlo.2026.104018}
}

RIS

TY  - JOUR
TI  - Economic case for universal hepatitis B birth dose vaccination in South Africa.
AU  - Benade M
AU  - Portnoy A
PY  - 2027
JO  - The Lancet. Global health
DO  - 10.1016/j.langlo.2026.104018
UR  - https://doi.org/10.1016/j.langlo.2026.104018
ER  -

APA

M, B., & A, P. (2027). Economic case for universal hepatitis B birth dose vaccination in South Africa.. The Lancet. Global health. https://doi.org/10.1016/j.langlo.2026.104018

Source records

pubmed · retrieved 2026-09-25T10:39:55.001Z